Sign in
4

Changes in Ownership

Indaptus Therapeutics, Inc. Filed Acc 0001493152-25-029356

Chief Financial Officer acquired 26,758 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sassi Nir Chief Financial Officer 2025-12-22 Grant or award +26,758 $2.03 $54,319 26,758 D
Loading xslF345X05/ownership.xml…